The Knowledge Group
The Knowledge Group

Amelia Feulner Baur, Ph.D, Founding Partner, McNeill Baur, PLLC to Speak at The Knowledge Group’s Live Webcast

New York, NY, November 05, 2016 --( The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Amelia Feulner Baur, Ph.D, Founding Partner, McNeill Baur, will speak at a 2-hour webcast entitled “USPTO's Subject Matter Eligibility: The Dos and Don'ts in 2016 and Beyond” This two-hour event is scheduled on November 15, 2016 @ 12:00 PM to 2:00 PM (ET).

Event Summary:

In May 2016, the United States Patent and Trademark Office (USPTO) released an updated guidance on the patent subject matter eligibility of natural products and new set of life science examples. The guidance aims to further improve and develop the quality and consistency of determinations and rejections of subject matter eligibility. The examples are designed to help patent applicants and examiners resolve eligibility issues in life sciences areas including vaccines and diagnostics. The updated guidance is vital for companies pursuing patent claims to diagnostic methods, biomarker detection, and other life science-based technologies.

In this live webcast, a panel of thought leaders and professionals assembled by The Knowledge Group will provide the audience with an in-depth discussion of the recent developments in USPTO’s Subject Matter Eligibility. Speakers will also present key issues and legal insights with regards to this remarkable topic.

Key topics include:

Evolution of USPTO guidance
Pre-2012 through SCOTUS/CAFC impact through 2014 IEG
- July 2015 update
- May 2016 iteration
- Next steps (including roundtables)
The 101 Pendulum from a case law perspective
- Mayo v. Prometheus (2012)
- Ariosa v. Sequenom (2015)
- Genetic Technologies v. Merial (2016)
- RLM v.Cellzdirect (2016)
- Bascom v. AT&T Mobility (2016)

Practical strategies for using section 101 in litigation and IPR:
- Defensively: (1) When to make a 101 Motion (e.g., 12(b)(6) at start of case, judgment on the pleadings, 101 and claim construction, summary judgment); (2) Utilizing 101 in the IPR, CBM, PGR context; and (3) Using 101 to drive settlement.
- Offensively: (1) Tips on overcoming a 101 Motion thus preserving the patent; and (2) Section 101 and venue choice.

About Amelia Feulner Baur, PhD

Founding partner Amelia Feulner Baur, PhD’s practice covers a broad spectrum of life science intellectual property issues, including patent preparation and prosecution, coordination of worldwide patent strategies, due diligence investigations including freedom-to-operate and validity opinions, and IP transaction work including acquisition, licensing, and option agreements. Amelia has led clients through inter partes review (IPR), reexaminations, interferences, and the settlement of patent disputes. Amelia has substantial legal experience in many biotechnology and pharmaceutical practice areas including personalized medicine, antibodies, diagnostic and detection methods, vaccines, and genomics. Amelia prides herself on providing personalized representation in precision medicine and biologics patent law.

About McNeill Baur PLLC

McNeill Baur PLLC, a 100% woman-owned IP firm, provides comprehensive patent law services to the biotech/pharma sector from invention through warning letters. Nearly all of attorneys and staff honed their legal talents at Finnegan, Henderson, Farabow, Garrett, & Dunner, LLP. Providing the same very high quality patent prosecution and counseling services as we did at a top patent firm, our firm focuses on being responsive, flexible, and experienced. Due to our small size and boutique-firm economics, we are able to offer more flexible billing options and lower hourly charges. We are also able to have more experienced attorney working directly on client matters, instead of simply overseeing them.

Our firm comprises five partners, one counsel, two associates, one patent agent, six patent prosecution coordinators, and administrative support staff. Seven of our professionals have PhD degrees, one has a Masters degree, and one was a former USPTO examiner. We have attorneys in Massachusetts, Pennsylvania, California, Georgia, and Wisconsin. Several of our attorneys have had leadership roles in widely recognized bar associations, including the ABA, the DC Bar, and the Boston Patent Law Association (BPLA) and our attorneys are invited to participate in speaking engagements throughout the country, in Europe, and though webinar formats.

About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series

The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, LLC, which examine trends, regulatory, and technology changes across a variety of industries. Its mission is to produce unbiased, objective, and educational live webcasts that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format.

The organization brings together the world's leading authorities and industry participants through informative two-hour webcasts to study the impact of changes and emerging trends. Hear from leading government officials/regulators, key thought leaders, and industry experts objectively analyze the latest trends and issues and their impact on industries.
The Knowledge Group
Thomas LaPointe, Jr., Executive Director
Therese Lumbao, Director
Account Management & Member Services